Commence Bio Email Format

Biotechnology ResearchMaryland, United States2-10 Employees

Commence Bio is a small biotechnology company based in Sparks Glencoe, Maryland, founded to pursue immunotherapies that re-educate the immune system using adult allogeneic mesenchymal stem cells. It is developing a proprietary approach that programs stem cells to act as immunomodulators, enabling them to migrate to sites of dysfunction and influence immune responses. Its lead candidate, CMB-200, targets acute optic neuritis and clinically isolated syndrome, conditions associated with multiple sclerosis.

Preclinical studies suggest these MSC-derived therapies have favorable safety profiles and potential efficacy, supporting ongoing development for cancer and inflammatory diseases. These efforts place the company in the biotechnology research industry as a contributor to cell-based immunotherapies. With a small, research-focused team, Commence Bio aims to advance immune-system-modulating cell therapies in oncology and inflammatory indications.

Sign up for free to view info

Company overview Employee directory